Last reviewed · How we verify
Huangqi Guizhi Wuwu decoction
A traditional Chinese herbal decoction that enhances qi circulation and promotes blood flow to improve microcirculation and tissue perfusion.
A traditional Chinese herbal decoction that enhances qi circulation and promotes blood flow to improve microcirculation and tissue perfusion. Used for Diabetic peripheral neuropathy, Microcirculatory disorders, Post-stroke recovery.
At a glance
| Generic name | Huangqi Guizhi Wuwu decoction |
|---|---|
| Also known as | Huangqi Guizhi Wuwu decoction placebo |
| Sponsor | The First Affiliated Hospital of Dalian Medical University |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular / Microcirculation |
| Phase | FDA-approved |
Mechanism of action
Huangqi Guizhi Wuwu decoction is a classical Chinese medicine formula combining Astragalus (Huangqi), Cinnamon twig (Guizhi), and other herbs to tonify qi and warm yang, thereby improving blood circulation and microvascular function. The formula is traditionally used to address deficiency patterns characterized by poor circulation and tissue nourishment.
Approved indications
- Diabetic peripheral neuropathy
- Microcirculatory disorders
- Post-stroke recovery
Common side effects
Key clinical trials
- HGWD Improve the Paclitaxel-related Neurotoxicity in Patients With BC (PHASE2)
- Huangqi Guizhi Wuwu Decoction in CKD Stage 2-4 Diabetic Nephropathy (NA)
- Yiqi Wenjing Prescriptions Preventive Efficacy of Oxaliplatin-induced Peripheral Neuropathy Clinical Trial (PHASE3)
- Clinical Trial Scheme of Huangqi Guizhi Wuwu Decoction (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: